|
The Prix Galien recognizes the technical, scientific, and clinical research
skills necessary to develop innovative medicines, and is now considered the
industry’s equivalent of the Nobel Prize, the highest accolade for
pharmaceutical research and development. The Population Council and Sheldon
Segal, distinguished scientist at the
organization, received the Prix Galien USA 2008 Pro Bono Humanum Award along
with other members of the coalition—Wyeth, Dow Corning and the late Judah
Folkman of Harvard University—that made possible the development and
distribution of implantable hormone delivery systems that are used for birth
control and family planning purposes by more than eight million women worldwide. |
News Release
- "The Population Council and Sheldon Segal to be awarded Prix Galien
USA Pro Bono Humanum Award: Recognizes organization and Segal for role
in developing implantable hormone delivery systems," news release, 23
September 2008. (full text)
 |
|
Dr. Sheldon Segal accepts the Prix Galien Pro
Bono Humanum Award. Photo courtesy of Loop Seven |
In the News
- "Pharmaceutical industry's 'Nobel Prize,'" The New York Sun,
22 September. (offsite
full text)
-
"How to treat the rare diseases that big pharma leaves behind," op-ed by
Sheldon Segal, AlterNet, 22 September. (offsite
full text)
Sheldon Segal
- Profile
- "Sheldon Segal, PhD, recipient of the Society of Family Planning's
2008 Lifetime Achievement Award," news release, September 2008. (full text)
- Recipient of the 2007 Joseph Bolivar DeLee Humanitarian Award from
the University of Chicago for an "extraordinary contribution to the
health of women and infants."
- "Sheldon J. Segal receives Lifetime Achievement Award from
International Academy of Human Reproduction," news release, 7 April
2005. (full text)
Population Council Contraception R&D
- "Building on decades of success: Pioneering contraceptive research and products,"
2008 fact sheet. (PDF)
(PDF en
español)
See Also
- World Contraception Day, 26 September 2008 (more)
|
|
